Kevin P Killeen

Title: Kevin P Killeen: Innovator in Oral Immunogenic Compositions

Introduction

Kevin P Killeen is a notable inventor based in Milton, MA (US). He has made significant contributions to the field of immunology, particularly through his innovative patent related to oral immunogenic compositions. His work focuses on providing dual protection against enterotoxigenic labile toxin (LT)-expressing bacteria.

Latest Patents

Kevin P Killeen holds a patent for oral immunogenic compositions that impart dual protection against enterotoxigenic labile toxin (LT)-expressing bacteria. This patent, which is a significant advancement in immunogenicity, involves the delivery of recombinant cholera toxin B antigen by attenuated, live bacterial vectors. The compositions exhibit dual immunogenicity and retain the ability to colonize gastrointestinal mucosa-associated lymphoid tissues. He has 1 patent to his name.

Career Highlights

Killeen is associated with Celldex Therapeutics Limited, where he continues to work on groundbreaking research in immunology. His career is marked by a commitment to developing innovative solutions that enhance human health through effective immunogenic strategies.

Collaborations

Throughout his career, Killeen has collaborated with esteemed colleagues, including Kenneth Roland and Lawrence J Thomas. These collaborations have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Kevin P Killeen is a distinguished inventor whose work in oral immunogenic compositions has the potential to significantly impact the field of immunology. His innovative approaches and collaborations highlight his dedication to advancing health solutions.